Boundless Bio, Inc. insider trading
Every open-market purchase and sale by Boundless Bio, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $1.9M 25 trades by 1 insider
3 months later: median +2.8% (−1.2% vs S&P 500) Insider sales, 5 years $134,031 3 trades by 3 insiders
3 months later: median +1.2% (−1.3% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Boundless Bio, Inc.’s insiders pay?
From June 29, 2026 to October 29, 2026, 3 insiders reported 9 open-market purchases and 2 sales not made under a pre-set plan in Boundless Bio, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Tang Kevin | 10% owner | 9 | — | — | 0 | — | October 29, 2026 |
| Gillis Steven and related entities | 10% owner | 0 | — | — | 1 | — | July 6, 2026 |
| Tang Capital Management LLC | 10% owner | 0 | — | — | 1 | — | August 28, 2026 |